Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Axel Brandes, Odense University Hospital, Syddansk Universitet
  • ,
  • Harry J G M Crijns, Maastricht University Medical Center
  • ,
  • Michiel Rienstra, University of Groningen
  • ,
  • Paulus Kirchhof, University of Birmingham
  • ,
  • Erik L Grove
  • Kenneth Bruun Pedersen, Odense University Hospital
  • ,
  • Isabelle C Van Gelder, Odense University Hospital, Syddansk Universitet, University of Groningen

Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

OriginalsprogEngelsk
TidsskriftEuropace
Vol/bind22
Nummer8
Sider (fra-til)1149-1161
Antal sider13
ISSN1099-5129
DOI
StatusUdgivet - aug. 2020

Bibliografisk note

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Se relationer på Aarhus Universitet Citationsformater

ID: 185692401